Edition: United Kingdom United Kingdom Select Region
Email: Passwd: or sign up free
One News Page
One News Page United Kingdom > Health > BioLineRx patent protection extended for schizophrenia drug
Open news article

BioLineRx patent protection extended for schizophrenia drug

Monday, 24 September 2012

TEL AVIV (Reuters) - Israeli biopharmaceutical development firm BioLineRx received a new patent from the U.S. Patent and Trademark Office for BL-1020, an experimental schizophrenia treatment.
Share on FacebookShare on Twitter Comment

You Might Like

Other recent news in Health

Saudi health minister sacked as MERS DEATH toll reaches 81Is GOOGLE GLASS the surgeon’s best friend?
Valeant, Bill Ackman bid $45B for Botox-maker ALLERGANWhite House thanks Seattle CEO for health-care outreach
Rare Birth Defects Still Spiking in WASHINGTON StateStocks heading higher...Home sales slip...Mixed earnings...Buying Botox...Using GOOGLE Glass
BREAST CANCER drug price cut urgedArkansas US Sen. JOHN BOOZMAN out of heart surgery
CALIFORNIA bill to curb medical marijuana passes key hurdleLooking Back at AMERICA's Struggle Against AIDS



comments powered by Disqus

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2014 One News Page Ltd. All Rights Reserved.  |  About us  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
One News Page - Top Headlines RSS Feed RSS  |  News for my Website  |  Free news search widget  |  Advertise  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |  One News Page on Facebook LIKE us on Facebook  One News Page on Twitter FOLLOW us on Twitter  One News Page on Google+ FIND us on Google+

Bullet: One News Page official news app for iPhone Bullet: Our news app for iPhone